These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3802029)

  • 21. Prediction of treatment outcome by cisplatin-DNA adduct formation in patients with stage III/IV head and neck squamous cell carcinoma, treated by concurrent cisplatin-radiation (RADPLAT).
    Hoebers FJ; Pluim D; Verheij M; Balm AJ; Bartelink H; Schellens JH; Begg AC
    Int J Cancer; 2006 Aug; 119(4):750-6. PubMed ID: 16550603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
    Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined pre-operative chemotherapy with intra-arterial cisplatin and continuous intravenous adriamycin for high grade osteosarcoma.
    Rha SY; Chung HC; Gong SJ; Shim KY; Ahn JB; Yang WI; Shin KH; Yoo NC; Kim JH; Roh JK; Lee CI; Kim BS
    Oncol Rep; 1999; 6(3):631-7. PubMed ID: 10203605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ovarian carcinoma biological nanotherapy: Comparison of the advantages and drawbacks of lipid, polymeric, and hybrid nanoparticles for cisplatin delivery.
    Zhang Y; Zhang P; Zhu T
    Biomed Pharmacother; 2019 Jan; 109():475-483. PubMed ID: 30399584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A model of experimental isolation perfusion using cis-platinum.
    Wile AG; Guilmette E; Friedberg H; Mason GR
    J Surg Oncol; 1982 Sep; 21(1):37-41. PubMed ID: 7202085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An in vitro-in vivo validation of the isolated perfused tumor and skin flap preparation as a model of cisplatin delivery to tumors.
    Vaden SL; Page RL; Riviere JE
    J Pharmacol Toxicol Methods; 1996 Jun; 35(3):173-7. PubMed ID: 8782096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue Distribution of Cisplatin by Intra-arterial Infusion Route in Comparison to Systemic Route: Implication to Therapy for Node-positive Bladder Cancer.
    Ichihashi A; Inamoto T; Uchimoto T; Nakamura KO; Komura K; Yano Y; Nishimura K; Kinoshita S; Nishio K; Fukushima T; Nakamori K; Matsunaga T; Tsutsumi T; Tsujino T; Uehara H; Takahara K; Yamamoto K; Kato R; Ijiri Y; Hayashi T; Azuma H
    In Vivo; 2023; 37(1):143-148. PubMed ID: 36593015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Injectable PLGA/Fe3O4 implants carrying cisplatin for synergistic magnetic hyperthermal ablation of rabbit VX2 tumor.
    Yang Y; Wang F; Zheng K; Deng L; Yang L; Zhang N; Xu C; Ran H; Wang Z; Wang Z; Zheng Y
    PLoS One; 2017; 12(5):e0177049. PubMed ID: 28472102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Induction chemotherapy with docetaxel plus cisplatin (TP regimen) followed by concurrent chemoradiotherapy with TP regimen versus cisplatin in treating locally advanced nasopharyngeal carcinoma].
    Xie FY; Zou GR; Hu WH; Qi SN; Peng M; Li JS
    Ai Zheng; 2009 Mar; 28(3):279-85. PubMed ID: 19619443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I study of highly selective supradose cisplatin infusions for advanced head and neck cancer.
    Robbins KT; Storniolo AM; Kerber C; Vicario D; Seagren S; Shea M; Hanchett C; Los G; Howell SB
    J Clin Oncol; 1994 Oct; 12(10):2113-20. PubMed ID: 7931481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The rabbit as an experimental model for regional chemotherapy. 1. Intra-arterial hindlimb infusion.
    Davidson T; Wallace J; Carnochan P
    Lab Anim; 1986 Oct; 20(4):343-6. PubMed ID: 3773441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intra-arterial versus intravenous cisplatinum (in addition to systemic Adriamycin and high dose methotrexate) in the neoadjuvant treatment of osteosarcoma of the extremities. results of a randomized study.
    Bacci G; Ruggieri P; Picci P; Mercuri M; Ferraro A; Tella G; Ferrari S; Bertoni F; Comandone A
    J Chemother; 1996 Feb; 8(1):70-81. PubMed ID: 8835114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ["Two route chemotherapy" of intra-arterial cis-diamminedichloroplatinum(II) and intravenous administration of its antidote, sodium thiosulfate, for rat bladder tumor].
    Sagiyama K
    Fukuoka Igaku Zasshi; 1983 Feb; 74(2):101-10. PubMed ID: 6682826
    [No Abstract]   [Full Text] [Related]  

  • 34. Potential advantages of loco-regional intra-arterial chemotherapy.
    Cagol PP; Pasqual E; Bacchetti S
    In Vivo; 2006; 20(6A):777-9. PubMed ID: 17203767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcatheter arterial embolization with cisplatin: apoptosis in VX2 tumour uterus transplants.
    Harima Y; Harima K; Hasegawa T; Shikata N; Tanaka Y
    Anticancer Res; 1996; 16(1):193-9. PubMed ID: 8615608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Response of murine tumors to matrix-associated cisplatin intratumoral implants.
    Yu NY; Conley FK; Luck EE; Brown DM
    NCI Monogr; 1988; (6):137-40. PubMed ID: 3352755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percent tumor necrosis as a predictor of treatment response in canine osteosarcoma.
    Powers BE; Withrow SJ; Thrall DE; Straw RC; LaRue SM; Page RL; Gillette EL
    Cancer; 1991 Jan; 67(1):126-34. PubMed ID: 1985708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotherapy of malignant gliomas: studies of the BTCG.
    Shapiro WR
    Rev Neurol (Paris); 1992; 148(6-7):428-34. PubMed ID: 1448662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pharmacokinetic study of intraperitoneal chemotherapy with high-dose cisplatin for advanced ovarian cancer].
    Deng C; Huang R; Lian L
    Zhonghua Fu Chan Ke Za Zhi; 1996 Mar; 31(3):159-62. PubMed ID: 8758790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chloroquine enhances the efficacy of cisplatin by suppressing autophagy in human adrenocortical carcinoma treatment.
    Qin L; Xu T; Xia L; Wang X; Zhang X; Zhang X; Zhu Z; Zhong S; Wang C; Shen Z
    Drug Des Devel Ther; 2016; 10():1035-45. PubMed ID: 27022243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.